Pan-Euro Pharma Primer: 'protein strangling' (ATTR): why should AZN lead in this $20bn peak cardio market?制药/制药装备Bernstein (Sanford C. Bernstein)2026-07-0638 页
China CDMO initiation: Complex molecules to drive the next decade of growth基因治疗/CDMO/基因疗法/免疫治疗Bernstein (Sanford C. Bernstein Group)2026-07-1494 页
